ImmunityBio, Inc.
IBRX
$7.25
$0.081.12%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -854.53M | -351.40M | -348.62M | -367.09M | -409.10M |
| Total Depreciation and Amortization | 15.98M | 15.43M | 15.80M | 16.30M | 16.83M |
| Total Amortization of Deferred Charges | 100.00K | 100.00K | 5.01M | 11.21M | 17.04M |
| Total Other Non-Cash Items | 576.86M | 85.27M | 58.87M | 38.51M | 42.64M |
| Change in Net Operating Assets | -32.79M | -54.33M | -50.76M | -48.48M | -37.56M |
| Cash from Operations | -294.39M | -304.94M | -319.70M | -349.56M | -370.16M |
| Capital Expenditure | -4.50M | -3.85M | -5.05M | -7.11M | -6.75M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -181.08M | -145.96M | -178.49M | 69.96M | 34.25M |
| Cash from Investing | -185.58M | -149.80M | -183.54M | 62.85M | 27.51M |
| Total Debt Issued | 77.95M | 2.88M | 0.00 | 0.00 | 96.96M |
| Total Debt Repaid | -2.04M | -1.16M | -16.00K | -26.00K | -43.00K |
| Issuance of Common Stock | 557.30M | 400.78M | 454.77M | 296.99M | 176.31M |
| Repurchase of Common Stock | -8.06M | -2.27M | -2.48M | -2.63M | -2.80M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 3.00K |
| Cash from Financing | 625.15M | 400.24M | 452.28M | 294.34M | 270.42M |
| Foreign Exchange rate Adjustments | 147.00K | 15.00K | 3.00K | 70.00K | 6.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 145.33M | -54.48M | -50.96M | 7.70M | -72.23M |